|
SFRS15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.933850E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.519700E-03 |
| Normal-vs-Stage2 |
5.522200E-01 |
| Normal-vs-Stage3 |
1.696440E-01 |
| Normal-vs-Stage4 |
8.821400E-01 |
| Stage1-vs-Stage2 |
1.306830E-01 |
| Stage1-vs-Stage3 |
2.408400E-01 |
| Stage1-vs-Stage4 |
1.290170E-02 |
| Stage2-vs-Stage3 |
6.543200E-01 |
| Stage2-vs-Stage4 |
6.362400E-01 |
| Stage3-vs-Stage4 |
2.597800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.214400E-02 |
| Normal-vs-AfricanAmerican |
1.409020E-01 |
| Normal-vs-Asian |
4.980600E-03 |
| Caucasian-vs-AfricanAmerican |
6.957000E-01 |
| Caucasian-vs-Asian |
1.334600E-01 |
| AfricanAmerican-vs-Asian |
2.556400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.755600E-01 |
| Normal-vs-Female |
1.775270E-04 |
| Male-vs-Female |
7.808300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.957800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.095800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.024400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.148800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.195800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.553000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.676800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.123600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.108600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.204200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.440100E-03 |
| Normal-vs-Grade 2 |
3.281000E-03 |
| Normal-vs-Grade 3 |
1.434640E-01 |
| Normal-vs-Grade 4 |
8.538000E-01 |
| Grade 1-vs-Grade 2 |
1.543800E-02 |
| Grade 1-vs-Grade 3 |
7.781600E-03 |
| Grade 1-vs-Grade 4 |
4.581700E-04 |
| Grade 2-vs-Grade 3 |
1.463560E-01 |
| Grade 2-vs-Grade 4 |
2.626000E-02 |
| Grade 3-vs-Grade 4 |
2.728400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.87212999999131E-05 |
| Normal-vs-ccB subtype |
7.105000E-01 |
| ccA subtype-vs-ccB subtype |
5.91759999999386E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.028950E-01 |
| Normal-vs-N1 |
7.453000E-01 |
| N0-vs-N1 |
3.800800E-01 |
|
|
